Madam Speaker, I share the member opposite's deep concern for patients who cannot access medication that at many times can be very helpful for rare diseases. We have heard about this, whether it is at a member of Parliament level, in our constituencies or at the national level, through the work that we have been doing on more affordable medication for Canadians. That is why the work that we are doing to develop a rare disease strategy in partnership with provinces and territories is so critical. By working together, we will be able to accelerate access to medication that can support these patients all across Canada.
In the House of Commons on January 31st, 2020. See this statement in context.